Protembis Announces Successful First-in-Human Use of Its ProtEmbo® Cerebral Protection System in European Trial

PRESS RELEASE: Protembis GmbH, a privately held medical device company, announced today the first clinical applications of its ProtEmbo® Cerebral Protection System to complement a transcatheter aortic valve replacement (TAVR) procedure. The...